Vitamin D3regulates the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells

Linda Kelsey, Parul Katoch, Anuttoma Ray, Shalini Mitra, Souvik Chakraborty, Ming-Fong Lin, Parmender P Mehta

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

1α-25(OH)2vitamin D3(1-25D), an active hormonal form of Vitamin D3, is a well-known chemopreventive and pro-differentiating agent. It has been shown to inhibit the growth of several prostate cancer cell lines. Gap junctions, formed of proteins called connexins (Cx), are ensembles of cell-cell channels, which permit the exchange of small growth regulatory molecules between adjoining cells. Cell-cell communication mediated by gap junctional channels is an important homeostatic control mechanism for regulating cell growth and differentiation. We have investigated the effect of 1-25D on the formation and degradation of gap junctions in an androgen-responsive prostate cancer cell line, LNCaP, which expresses retrovirally-introduced Cx32. Connexin32 is expressed by the luminal and well-differentiated cells of normal prostate and prostate tumors. Our results document that 1-25D enhances the expression of Cx32 and its subsequent assembly into gap junctions. Our results further show that 1-25D prevents androgen-regulated degradation of Cx32, post-translationally, independent of androgen receptor (AR)-mediated signaling. Finally, our findings document that formation of gap junctions sensitizes Cx32-expressing LNCaP cells to the growth inhibitory effects of 1-25D and alters their morphology. These findings suggest that the growth-inhibitory effects of 1-25D in LNCaP cells may be related to its ability to modulate the assembly of Cx32 into gap junctions.

Original languageEnglish (US)
Article numbere106437
JournalPloS one
Volume9
Issue number9
DOIs
StatePublished - Jan 1 2014

Fingerprint

gap junctions
Gap Junctions
prostatic neoplasms
androgens
Vitamins
Androgens
vitamins
Prostatic Neoplasms
Cells
Degradation
degradation
Growth
cells
Connexins
Cholecalciferol
Androgen Receptors
Cell growth
Prostate
cell lines
connexins

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Cite this

Vitamin D3regulates the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells. / Kelsey, Linda; Katoch, Parul; Ray, Anuttoma; Mitra, Shalini; Chakraborty, Souvik; Lin, Ming-Fong; Mehta, Parmender P.

In: PloS one, Vol. 9, No. 9, e106437, 01.01.2014.

Research output: Contribution to journalArticle

Kelsey, Linda ; Katoch, Parul ; Ray, Anuttoma ; Mitra, Shalini ; Chakraborty, Souvik ; Lin, Ming-Fong ; Mehta, Parmender P. / Vitamin D3regulates the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells. In: PloS one. 2014 ; Vol. 9, No. 9.
@article{8541d501f9534c739c5df7fd96144030,
title = "Vitamin D3regulates the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells",
abstract = "1α-25(OH)2vitamin D3(1-25D), an active hormonal form of Vitamin D3, is a well-known chemopreventive and pro-differentiating agent. It has been shown to inhibit the growth of several prostate cancer cell lines. Gap junctions, formed of proteins called connexins (Cx), are ensembles of cell-cell channels, which permit the exchange of small growth regulatory molecules between adjoining cells. Cell-cell communication mediated by gap junctional channels is an important homeostatic control mechanism for regulating cell growth and differentiation. We have investigated the effect of 1-25D on the formation and degradation of gap junctions in an androgen-responsive prostate cancer cell line, LNCaP, which expresses retrovirally-introduced Cx32. Connexin32 is expressed by the luminal and well-differentiated cells of normal prostate and prostate tumors. Our results document that 1-25D enhances the expression of Cx32 and its subsequent assembly into gap junctions. Our results further show that 1-25D prevents androgen-regulated degradation of Cx32, post-translationally, independent of androgen receptor (AR)-mediated signaling. Finally, our findings document that formation of gap junctions sensitizes Cx32-expressing LNCaP cells to the growth inhibitory effects of 1-25D and alters their morphology. These findings suggest that the growth-inhibitory effects of 1-25D in LNCaP cells may be related to its ability to modulate the assembly of Cx32 into gap junctions.",
author = "Linda Kelsey and Parul Katoch and Anuttoma Ray and Shalini Mitra and Souvik Chakraborty and Ming-Fong Lin and Mehta, {Parmender P}",
year = "2014",
month = "1",
day = "1",
doi = "10.1371/journal.pone.0106437",
language = "English (US)",
volume = "9",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "9",

}

TY - JOUR

T1 - Vitamin D3regulates the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells

AU - Kelsey, Linda

AU - Katoch, Parul

AU - Ray, Anuttoma

AU - Mitra, Shalini

AU - Chakraborty, Souvik

AU - Lin, Ming-Fong

AU - Mehta, Parmender P

PY - 2014/1/1

Y1 - 2014/1/1

N2 - 1α-25(OH)2vitamin D3(1-25D), an active hormonal form of Vitamin D3, is a well-known chemopreventive and pro-differentiating agent. It has been shown to inhibit the growth of several prostate cancer cell lines. Gap junctions, formed of proteins called connexins (Cx), are ensembles of cell-cell channels, which permit the exchange of small growth regulatory molecules between adjoining cells. Cell-cell communication mediated by gap junctional channels is an important homeostatic control mechanism for regulating cell growth and differentiation. We have investigated the effect of 1-25D on the formation and degradation of gap junctions in an androgen-responsive prostate cancer cell line, LNCaP, which expresses retrovirally-introduced Cx32. Connexin32 is expressed by the luminal and well-differentiated cells of normal prostate and prostate tumors. Our results document that 1-25D enhances the expression of Cx32 and its subsequent assembly into gap junctions. Our results further show that 1-25D prevents androgen-regulated degradation of Cx32, post-translationally, independent of androgen receptor (AR)-mediated signaling. Finally, our findings document that formation of gap junctions sensitizes Cx32-expressing LNCaP cells to the growth inhibitory effects of 1-25D and alters their morphology. These findings suggest that the growth-inhibitory effects of 1-25D in LNCaP cells may be related to its ability to modulate the assembly of Cx32 into gap junctions.

AB - 1α-25(OH)2vitamin D3(1-25D), an active hormonal form of Vitamin D3, is a well-known chemopreventive and pro-differentiating agent. It has been shown to inhibit the growth of several prostate cancer cell lines. Gap junctions, formed of proteins called connexins (Cx), are ensembles of cell-cell channels, which permit the exchange of small growth regulatory molecules between adjoining cells. Cell-cell communication mediated by gap junctional channels is an important homeostatic control mechanism for regulating cell growth and differentiation. We have investigated the effect of 1-25D on the formation and degradation of gap junctions in an androgen-responsive prostate cancer cell line, LNCaP, which expresses retrovirally-introduced Cx32. Connexin32 is expressed by the luminal and well-differentiated cells of normal prostate and prostate tumors. Our results document that 1-25D enhances the expression of Cx32 and its subsequent assembly into gap junctions. Our results further show that 1-25D prevents androgen-regulated degradation of Cx32, post-translationally, independent of androgen receptor (AR)-mediated signaling. Finally, our findings document that formation of gap junctions sensitizes Cx32-expressing LNCaP cells to the growth inhibitory effects of 1-25D and alters their morphology. These findings suggest that the growth-inhibitory effects of 1-25D in LNCaP cells may be related to its ability to modulate the assembly of Cx32 into gap junctions.

UR - http://www.scopus.com/inward/record.url?scp=84906959438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906959438&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0106437

DO - 10.1371/journal.pone.0106437

M3 - Article

C2 - 25188420

AN - SCOPUS:84906959438

VL - 9

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 9

M1 - e106437

ER -